Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab

David W. Ayer, Vladimir Skljarevski, Janet H. Ford, Allen W. Nyhuis, Richard B. Lipton, Sheena K. Aurora

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab'. Together they form a unique fingerprint.

Medicine & Life Sciences